Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure

Beverly A. Rothermel, Kambeez Berenji, Paul Tannous, William Kutschke, Asim Dey, Bridgid Nolan, Ki Dong Yoo, Elaine Demetroulis, Michael Gimbel, Barry Cabuay, Mohsen Karimi, Joseph A. Hill*

*Corresponding author for this work

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Hypertrophic growth of the myocardium occurs in most forms of heart failure and may contribute to the pathogenesis of the failure state. Little is known about the regulatory mechanisms governing the often-coexisting phenotypes of hypertrophy, systolic failure, and diastolic stiffness that characterize clinical disease. We hypothesized that intracellular signaling pathways are differentially activated by graded degrees of hemodynamic stress. To test this, we developed models of graded pressure stress in mice and used them to directly compare compensated hypertrophy and pressure-overload heart failure. Surgical interventions were designed to be similar, on either side of a threshold separating compensated from decompensated responses. Our findings revealed two dramatically different hypertrophic phenotypes with only modest differences in the activation of relevant intracellular signaling pathways. Furthermore, we uncovered a functional requirement of calcineurin signaling in each model such that calcineurin suppression blunted hypertrophic growth. Remarkably, in each case, suppression of calcineurin signaling was not associated with clinical deterioration or increased mortality. Profiles of stress-response signaling and Ca2+ handling differ between the steady-state, maintenance phases of load-induced cardiac hypertrophy and failure. This information may be useful in identifying novel targets of therapy in chronic disease.

Original languageEnglish (US)
Pages (from-to)18-27
Number of pages10
JournalPhysiological Genomics
Volume23
Issue number1
DOIs
StatePublished - Sep 21 2005

Fingerprint

Calcineurin
Cardiomegaly
Heart Failure
Hypertrophy
Phenotype
Pressure
Growth
Myocardium
Chronic Disease
Hemodynamics
Maintenance
Mortality
Therapeutics

Keywords

  • Myocardium
  • Signal transduction

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

Rothermel, Beverly A. ; Berenji, Kambeez ; Tannous, Paul ; Kutschke, William ; Dey, Asim ; Nolan, Bridgid ; Yoo, Ki Dong ; Demetroulis, Elaine ; Gimbel, Michael ; Cabuay, Barry ; Karimi, Mohsen ; Hill, Joseph A. / Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. In: Physiological Genomics. 2005 ; Vol. 23, No. 1. pp. 18-27.
@article{bf36a29ce7e64df79b47e4ecd6e7ae2e,
title = "Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure",
abstract = "Hypertrophic growth of the myocardium occurs in most forms of heart failure and may contribute to the pathogenesis of the failure state. Little is known about the regulatory mechanisms governing the often-coexisting phenotypes of hypertrophy, systolic failure, and diastolic stiffness that characterize clinical disease. We hypothesized that intracellular signaling pathways are differentially activated by graded degrees of hemodynamic stress. To test this, we developed models of graded pressure stress in mice and used them to directly compare compensated hypertrophy and pressure-overload heart failure. Surgical interventions were designed to be similar, on either side of a threshold separating compensated from decompensated responses. Our findings revealed two dramatically different hypertrophic phenotypes with only modest differences in the activation of relevant intracellular signaling pathways. Furthermore, we uncovered a functional requirement of calcineurin signaling in each model such that calcineurin suppression blunted hypertrophic growth. Remarkably, in each case, suppression of calcineurin signaling was not associated with clinical deterioration or increased mortality. Profiles of stress-response signaling and Ca2+ handling differ between the steady-state, maintenance phases of load-induced cardiac hypertrophy and failure. This information may be useful in identifying novel targets of therapy in chronic disease.",
keywords = "Myocardium, Signal transduction",
author = "Rothermel, {Beverly A.} and Kambeez Berenji and Paul Tannous and William Kutschke and Asim Dey and Bridgid Nolan and Yoo, {Ki Dong} and Elaine Demetroulis and Michael Gimbel and Barry Cabuay and Mohsen Karimi and Hill, {Joseph A.}",
year = "2005",
month = "9",
day = "21",
doi = "10.1152/physiolgenomics.00061.2005",
language = "English (US)",
volume = "23",
pages = "18--27",
journal = "Physiological Genomics",
issn = "1531-2267",
publisher = "American Physiological Society",
number = "1",

}

Rothermel, BA, Berenji, K, Tannous, P, Kutschke, W, Dey, A, Nolan, B, Yoo, KD, Demetroulis, E, Gimbel, M, Cabuay, B, Karimi, M & Hill, JA 2005, 'Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure', Physiological Genomics, vol. 23, no. 1, pp. 18-27. https://doi.org/10.1152/physiolgenomics.00061.2005

Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure. / Rothermel, Beverly A.; Berenji, Kambeez; Tannous, Paul; Kutschke, William; Dey, Asim; Nolan, Bridgid; Yoo, Ki Dong; Demetroulis, Elaine; Gimbel, Michael; Cabuay, Barry; Karimi, Mohsen; Hill, Joseph A.

In: Physiological Genomics, Vol. 23, No. 1, 21.09.2005, p. 18-27.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential activation of stress-response signaling in load-induced cardiac hypertrophy and failure

AU - Rothermel, Beverly A.

AU - Berenji, Kambeez

AU - Tannous, Paul

AU - Kutschke, William

AU - Dey, Asim

AU - Nolan, Bridgid

AU - Yoo, Ki Dong

AU - Demetroulis, Elaine

AU - Gimbel, Michael

AU - Cabuay, Barry

AU - Karimi, Mohsen

AU - Hill, Joseph A.

PY - 2005/9/21

Y1 - 2005/9/21

N2 - Hypertrophic growth of the myocardium occurs in most forms of heart failure and may contribute to the pathogenesis of the failure state. Little is known about the regulatory mechanisms governing the often-coexisting phenotypes of hypertrophy, systolic failure, and diastolic stiffness that characterize clinical disease. We hypothesized that intracellular signaling pathways are differentially activated by graded degrees of hemodynamic stress. To test this, we developed models of graded pressure stress in mice and used them to directly compare compensated hypertrophy and pressure-overload heart failure. Surgical interventions were designed to be similar, on either side of a threshold separating compensated from decompensated responses. Our findings revealed two dramatically different hypertrophic phenotypes with only modest differences in the activation of relevant intracellular signaling pathways. Furthermore, we uncovered a functional requirement of calcineurin signaling in each model such that calcineurin suppression blunted hypertrophic growth. Remarkably, in each case, suppression of calcineurin signaling was not associated with clinical deterioration or increased mortality. Profiles of stress-response signaling and Ca2+ handling differ between the steady-state, maintenance phases of load-induced cardiac hypertrophy and failure. This information may be useful in identifying novel targets of therapy in chronic disease.

AB - Hypertrophic growth of the myocardium occurs in most forms of heart failure and may contribute to the pathogenesis of the failure state. Little is known about the regulatory mechanisms governing the often-coexisting phenotypes of hypertrophy, systolic failure, and diastolic stiffness that characterize clinical disease. We hypothesized that intracellular signaling pathways are differentially activated by graded degrees of hemodynamic stress. To test this, we developed models of graded pressure stress in mice and used them to directly compare compensated hypertrophy and pressure-overload heart failure. Surgical interventions were designed to be similar, on either side of a threshold separating compensated from decompensated responses. Our findings revealed two dramatically different hypertrophic phenotypes with only modest differences in the activation of relevant intracellular signaling pathways. Furthermore, we uncovered a functional requirement of calcineurin signaling in each model such that calcineurin suppression blunted hypertrophic growth. Remarkably, in each case, suppression of calcineurin signaling was not associated with clinical deterioration or increased mortality. Profiles of stress-response signaling and Ca2+ handling differ between the steady-state, maintenance phases of load-induced cardiac hypertrophy and failure. This information may be useful in identifying novel targets of therapy in chronic disease.

KW - Myocardium

KW - Signal transduction

UR - http://www.scopus.com/inward/record.url?scp=33645764690&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645764690&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00061.2005

DO - 10.1152/physiolgenomics.00061.2005

M3 - Article

VL - 23

SP - 18

EP - 27

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1531-2267

IS - 1

ER -